The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 23, 2023

Filed:

Jul. 24, 2018
Applicants:

Commissariat a L'energie Atomique ET Aux Energies Alternatives, Paris, FR;

Assistance Publique—hopitaux DE Paris, Paris, FR;

Inventors:

Edgardo D. Carosella, Paris, FR;

Diana Tronik-Le Roux, Meudon, FR;

Jean-Philippe Deslys, La Celle Saint-Cloud, FR;

Jérôme Verine, Antony, FR;

François Desgrandchamps, Paris, FR;

Nathalie Rouas-Freiss, Paris, FR;

Joël Le Maoult, Melun, FR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/17 (2006.01); C07K 14/47 (2006.01); C07K 14/74 (2006.01); C07K 16/28 (2006.01); C12N 15/79 (2006.01);
U.S. Cl.
CPC ...
C07K 14/70539 (2013.01); A61K 38/1709 (2013.01); A61K 38/1774 (2013.01); C07K 14/47 (2013.01); C07K 16/2833 (2013.01); C12N 15/79 (2013.01); C07K 2317/33 (2013.01);
Abstract

Embodiments of the disclosure pertain to the field of HLA-G molecules and their therapeutic use. The disclosure pertains to new HLA-G isoforms, that is to say new RNA transcripts and proteins deriving from the HLA-G gene, pharmaceutical composition comprising thereof, as well as primers specific of these transcripts and antibodies specific of these proteins. The disclosure further pertains to the diagnostic or therapeutic use of these molecules.


Find Patent Forward Citations

Loading…